MYC and cancer: These changes result in the increased abundance of proto‐oncogenes, such as c‐MYC [44], JUN [45] or NOTCH, driving cell proliferation, dedifferentiation, metabolic changes, DNA damage control, immune evasion and proteostatic stress management, the ‘hallmarks of cancer’ [34].